The ability to understand the pharmaceutical industry is a very difficult task for the everyday consumer because it can be very confusing. Last year, the generic drug company Lannett started raising the prices of their products. Lannett decided to raise the price of their antipsychotic drug fluphenazine. In 2012 the price of the price of fluphenazine was $43.50 for 100, 10-milligram a capsule. In 2017 the same drug went up to $870. That is a drastic jump. The majority of the people who take fluphenazine are the elderly. Medicaid only covers 65% of lannett’s version of the prescription of fluphenazine (Morgenson, 2017). In observation of lannett’s pricing methods, the generic drug manufacture market is a good idea of an Oligopoly because that